BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29883237)

  • 1. Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced.
    Leonard A; Tisdale JF
    Expert Rev Hematol; 2018 Jul; 11(7):547-565. PubMed ID: 29883237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease.
    Gluckman E
    Hematology Am Soc Hematol Educ Program; 2013; 2013():370-6. PubMed ID: 24319206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
    Talano JA; Cairo MS
    Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Leonard A; Tisdale J; Abraham A
    Br J Haematol; 2020 May; 189(3):408-423. PubMed ID: 32034776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
    Inam Z; Tisdale JF; Leonard A
    Expert Rev Hematol; 2023; 16(11):879-903. PubMed ID: 37800996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
    Tanhehco YC; Bhatia M
    Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure.
    Lawal RA; Walters MC; Fitzhugh CD
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1313-1335. PubMed ID: 36400545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
    Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for sickle cell disease.
    Leonard A; Tisdale JF
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):542-547. PubMed ID: 38066927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.
    Arnold SD; Bhatia M; Horan J; Krishnamurti L
    Br J Haematol; 2016 Aug; 174(4):515-25. PubMed ID: 27255787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
    Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
    Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogenic hematopoietic stem cell transplantation in sickle cell disease.
    Furstenau DK; Tisdale JF
    Transfus Apher Sci; 2021 Feb; 60(1):103057. PubMed ID: 33485798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.
    Kassim AA; Leonard A
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
    Leonard A; Bertaina A; Bonfim C; Cohen S; Prockop S; Purtill D; Russell A; Boelens JJ; Wynn R; Ruggeri A; Abraham A
    Cytotherapy; 2022 Mar; 24(3):249-261. PubMed ID: 34879990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
    Kassim AA; Sharma D
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative Therapies for Sickle Cell Disease.
    Khemani K; Katoch D; Krishnamurti L
    Ochsner J; 2019; 19(2):131-137. PubMed ID: 31258425
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.
    Hsieh MM; Fitzhugh CD; Tisdale JF
    Blood; 2011 Aug; 118(5):1197-207. PubMed ID: 21628400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease.
    Limerick E; Fitzhugh C
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31731790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Aslam HM; Yousuf S; Kassim A; Iqbal SM; Hashmi SK
    Bone Marrow Transplant; 2018 Nov; 53(11):1390-1400. PubMed ID: 29728697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.